• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Researchers debut digestible battery

August 24, 2016 By drugdelivery

Carnegie Mellon researcher Chris Bettinger with digestible batteryBy Sarah Faulkner

Researchers at Carnegie Mellon University unveiled an ingestible battery that could eventually power medical devices, including drug-delivery mechanisms.

The inspiration came when Christopher Bettinger, PhD, and his team noted that melanin pigments bind and unbind metallic ions. “We thought, ‘This is just like a battery,'” Bettinger said.

The melanin pigments are encapsulated by a 3D-printed shell, easily digestible because it’s made of gelatin. After swallowing the battery, it comes into contact with charged molecules in the stomach, which creates a current. This electrical field could stimulate the release of chemicals, a necessary component for targeted therapies. The research was presented yesterday at the at the annual meeting of the American Chemical Society in Philadelphia.

Bettinger chose to focus on naturally occurring materials to create low-toxicity batteries. “We have to think about biologically-derived materials that could replace some of these things you might find in a RadioShack,” he explained.

The team reported that the battery could power a 5milliWatt device for up to 18 hours. Longevity isn’t an issue, since 10-20 hours offers enough time for a device to work in the body.

Moving forward, they hope to develop different types of ingestible batteries and packaging that could effectively deliver the battery to the stomach.

Filed Under: Drug-Device Combinations Tagged With: Carnegie Mellon

IN CASE YOU MISSED IT

  • Glucotrack now expects spring 2026 FDA IDE submission for implantable CGM
  • Carrot, Oura, Dexcom partner on biosensor insights for fertility
  • Vivani to initiate study of semaglutide implant in 2026
  • What the launch of Mobi for Android means for Tandem, people with diabetes
  • Go-Pen wins CE mark for user-fillable insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS